Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M50,117Revenue $M20,272Net Margin (%)13.6Altman Z-Score2.0
Enterprise Value $M57,779EPS $3.6Operating Margin %18.4Piotroski F-Score8
P/E(ttm)18.5Beneish M-Score-2.8Pre-tax Margin (%)16.3Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %14.6Quick Ratio0.9Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %4.7Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow14.4y-y EBITDA Growth Rate %60.3ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %2.3PEG3.9ROE % (ttm)11.9Less Shares Outstanding y-yN
Payout Ratio %43.0Shares Outstanding M848ROIC % (ttm)9.6Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAGeorge Soros 2015-03-31 Sold Out -3.1%$54.93 - $62.65
($58.14)
$ 58.911%Sold Out0
TEVAVanguard Health Care Fund 2015-03-31 Reduce-0.41%$54.93 - $62.65
($58.14)
$ 58.911%Reduce 61.47%1,896,960
TEVAFirst Eagle Investment 2015-03-31 Add0.26%$54.93 - $62.65
($58.14)
$ 58.911%Add 71.77%4,205,481
TEVANWQ Managers 2015-03-31 Reduce-0.24%$54.93 - $62.65
($58.14)
$ 58.911%Reduce 8.53%3,669,079
TEVADavid Dreman 2015-03-31 Reduce-0.09%$54.93 - $62.65
($58.14)
$ 58.911%Reduce 16.44%100,133
TEVAMichael Price 2015-03-31 Reduce-0.05%$54.93 - $62.65
($58.14)
$ 58.911%Reduce 1.61%440,300
TEVAJames Barrow 2015-03-31 Reduce-0.05%$54.93 - $62.65
($58.14)
$ 58.911%Reduce 5.85%10,189,904
TEVARonald Muhlenkamp 2015-03-31 Add$54.93 - $62.65
($58.14)
$ 58.911%Add 0.18%176,710
TEVAJohn Keeley 2015-03-31 Reduce$54.93 - $62.65
($58.14)
$ 58.911%Reduce 2.95%36,835
TEVATom Gayner 2014-12-31 Sold Out -0.67%$49.86 - $58.72
($55.72)
$ 58.916%Sold Out0
TEVAGeorge Soros 2014-12-31 Reduce-0.55%$49.86 - $58.72
($55.77)
$ 58.916%Reduce 22.01%4,859,966
TEVANWQ Managers 2014-12-31 Reduce-0.39%$49.86 - $58.72
($55.72)
$ 58.916%Reduce 14.62%4,011,187
TEVAMichael Price 2014-12-31 Reduce-0.36%$49.86 - $58.72
($55.77)
$ 58.916%Reduce 10.50%447,500
TEVADavid Dreman 2014-12-31 Reduce-0.16%$49.86 - $58.72
($55.77)
$ 58.916%Reduce 23.89%119,838
TEVAFirst Eagle Investment 2014-12-31 Add0.14%$49.86 - $58.72
($55.72)
$ 58.916%Add 72.35%2,448,310
TEVAVanguard Health Care Fund 2014-12-31 Reduce-0.06%$49.86 - $58.72
($55.76)
$ 58.916%Reduce 8.19%4,923,200
TEVAJames Barrow 2014-12-31 Add0.03%$49.86 - $58.72
($55.76)
$ 58.916%Add 4.37%10,823,115
TEVAJohn Keeley 2014-12-31 Reduce-0.01%$49.86 - $58.72
($55.72)
$ 58.916%Reduce 20.45%37,955
TEVARonald Muhlenkamp 2014-12-31 Reduce$49.86 - $58.72
($55.76)
$ 58.916%Reduce 0.27%176,385
TEVACharles Brandes 2014-12-31 Buy $49.86 - $58.72
($55.72)
$ 58.916%New holding3,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    Paul Tudor Jones Buys Stakes in ADP and Visa Jun 19 2015 
    KEELEY All Cap Value Fund First Quarter 2015 Commentary Jun 17 2015 
    Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
    Leon Cooperman's Top Holdings Look Attractive Jun 09 2015 
    Actavis Stock – A Must Have For Long-Term Investors May 27 2015 
    Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
    Stanley Druckenmiller's Top 5 New Stocks May 25 2015 
    Teva Puts Forth Its Best Bid To Acquire Mylan Apr 25 2015 
    Teva Eyeing Mylan For $40 Billion Apr 23 2015 
    M&A’s Driving The Stock Indexes Ahead Apr 06 2015 

    More From Other Websites
    A New Rider in the Perrigo, Mylan, Teva Merger Merry-Go-Round Jun 30 2015
    Unusual Covered Call Opportunity Teva Pharmaceuticals Jun 30 2015
    Pharma bulls like Teva, Horizon Jun 30 2015
    Cash is not Always King in Pharma Pay-to-Delay Deals: Appeals Court Jun 26 2015
    Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO... Jun 25 2015
    Short Sellers Become More Focused on Big Pharma Jun 25 2015
    Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO... Jun 25 2015
    Alder Bio Up As Credit Suisse Lauds Migraine Drug Jun 24 2015
    Teva Launches PainMatters.com to Support Responsible Pain Management Jun 24 2015
    Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines... Jun 23 2015
    Mylan CFO to meet Tel Aviv bourse chief to discuss listing - source Jun 23 2015
    Eagle Pharma Has 'Several Upcoming Catalysts' And Is A Buy, RBC Says Jun 22 2015
    Question for FTC: Is Mylan based at Southpointe or in the Netherlands? Jun 22 2015
    Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog Jun 22 2015
    4 Top S&P 500 Stocks to Buy Not Domiciled in the US Jun 22 2015
    After Tax Inversion, Mylan Seeks Uncle Sam’s Aid in Teva Dispute Jun 19 2015
    Paul Tudor Jones Buys Stakes in ADP and Visa Jun 19 2015
    Momenta Gains on Generic Copaxone's Launch in U.S. - Analyst Blog Jun 19 2015
    Law Firm Reed Smith Names Steven Agnoli CIO Jun 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK